RxDoctor Payments Data

Francisco Capo, MD

Urology · San Juan, PRNPI 1063529998

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Verity Pharmaceuticals Inc. accounts for 92.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $18,353 and has fallen 99.4% since, to $108 in 2025.

$37,710in general payments, 2019–2025

Across 42 payments — averaging $897.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Verity Pharmaceuticals Inc.$35K
  • Boston Scientific$1K
  • Teleflex LLC$493
  • Johnson & Johnson$301
  • AbbVie$188
  • BD$130
  • plus $260 from 4 others

What the payments were for

  • Consulting fees$17,00045%
  • Speaking & faculty fees$18,00048%
  • Food & beverage$2,6877%
  • Education$230%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,710 in reported general payments places this provider in the 85th percentile of 122 urology providers in Puerto Rico.

See all urology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$54,488
Medicare patients
97
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Bicalutamide284$10,994
Sildenafil Citrate109$3,233
Tamsulosin Hcl85$1,517
Ciprofloxacin Hcl82$853
ValacyclovirValacyclovir Hcl11$730
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip39$708
Oxybutynin Chloride ErOxybutynin Chloride18$567
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$476
Cefadroxil34$242
Levofloxacin36$238
Tadalafil14$190
Celecoxib46$145

Paid to pharmacies, not to this prescriber.

Other urology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →